Engineered modeling and the secrets of Parkinson's disease
- 1 November 2001
- journal article
- review article
- Published by Elsevier in Trends in Neurosciences
- Vol. 24 (11) , S49-S55
- https://doi.org/10.1016/s0166-2236(00)01984-6
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Synaptic Vesicle Transporter Expression Regulates Vesicle Phenotype and Quantal SizeJournal of Neuroscience, 2000
- Catecholamine Synthesis is Mediated by Tyrosinase in the Absence of Tyrosine HydroxylaseJournal of Neuroscience, 1999
- NEW INSIGHTS INTO DOPAMINERGIC RECEPTOR FUNCTION USING ANTISENSE AND GENETICALLY ALTERED ANIMALSAnnual Review of Pharmacology and Toxicology, 1999
- MONOAMINE OXIDASE: From Genes to BehaviorAnnual Review of Neuroscience, 1999
- Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson diseaseNature Medicine, 1998
- Catechol- O -methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behaviorProceedings of the National Academy of Sciences, 1998
- Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17Nature, 1998
- Knockout of the Vesicular Monoamine Transporter 2 Gene Results in Neonatal Death and Supersensitivity to Cocaine and AmphetamineNeuron, 1997
- Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporterNature, 1996
- Dopamine-deficient mice are severely hypoactive, adipsic, and aphagicCell, 1995